Print Magazine
Brussels Morning Newspaper
Wednesday, June 29, 2022
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions

COVID-19 —EU mobilises aid to India but rejects vaccine IP waiver

Marta Pacheco by Marta Pacheco
6 May 2021
in EU Institutions
COVID-19 —EU mobilises aid to India but rejects vaccine IP waiver
Share on FacebookShare on Twitter

Brussels (Brussels Morning) The European Commission is to mobilise an additional 2.2 billion euro to support India as it struggles to cope with the drastic surge of COVID-19 cases. The EU’s executive announcement comes a week after the European Parliament’s rejected a proposal to suspend COVID-19 vaccines intellectual property (IP) waivers for India and South Africa.

MEP José Gusmāo (GUE-NGL) described the Parliament’s vote rejecting the vaccine IP waiver as “disappointing”.

The amendment was rejected on 28 April by 454 votes to 162. With few exceptions, the centre-right European People’s Party (EPP), the socialists (S&D) and the liberals (Renew Europe) voted against the proposal.

“A vote to remember when these parties lament the slowness of vaccination or the appearance of variants from other continents, where vaccination has barely begun and where the virus runs free”, Gusmāo tweeted.

Meanwhile, the additional funding announced by the Commission will support a World Health Organisation (WHO) six-month case management programme for COVID-19 patients, in addition to strengthening laboratory capacity for COVID-19 testing. 

“We are providing additional EU support towards the fight against COVID-19 in India. This comes on top of the generous and swift assistance from EU member states that stepped up as part of Team Europe to offer critical supplies of oxygen, ventilators and medicines over the last few days”, Commissioner for Crisis Management, Janez Lenarčič, announced in a 5 May press statement. 

India appealed for a suspension of IP rights for COVID-19 treatments and vaccines in a proposal it submitted to the World Trade Organisation (WTO) a year ago, a request that since gained the support of more than 100 countries.

The EPP group in the Parliament expressed “fully agreement” that vaccinations needed to speed up in developing countries, but claimed that while “waiving the intellectual property rights looks like a good solution, it is not”.

US supports IP waiver

The US had declared its support for a COVID-19 vaccine IP waiver to help end the pandemic.

“These extraordinary times and circumstances call for extraordinary measures”, US Trade Ambassador Katherine Tai, declared in announcing that the US will participate in WTO negotiations to make that happen.

With the rich nations having acquired most of the global supply of COVID-19 doses, US President Joe Biden has come under increasing pressure to agree to waivers so that vaccine manufacturers can ramp up production and increase vaccine distribution to more countries.

Tags: Biweekly MartaBrussels DirectMain-Slider

Latest post

Ansongo,,Mali,-,December,2015,:,Daily,Life,Of,French

Report reveals deep links between Airbus and Chinese military industry

3 hours ago
EU’s urban population at risk due to heavy air pollution, EEA says

EU to ban sale of new internal combustion cars in 2035

6 hours ago

Most Read

  • These are the 10 highest paying jobs in the Europe in 2022

    These are the 10 highest paying jobs in the Europe in 2022

    0 shares
    Share 0 Tweet 0
  • What Are The Highest Paying Jobs In Luxembourg?

    0 shares
    Share 0 Tweet 0
  • Energy Recovery Fund

    0 shares
    Share 0 Tweet 0
  • What Are The Highest Paying Jobs In Finland?

    0 shares
    Share 0 Tweet 0
  • A taste of Croatian flavors of the diplomacy in Brussels

    0 shares
    Share 0 Tweet 0
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Belgium News
  • Brussels
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Print Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT